In the US, there are approximately 1 million adults with congenital heart disease, with 20,000 new patients reaching adolescence each year.  With early diagnosis in childhood and improved medical, surgical and ICU care, the number of adults will continue to rise.  Despite improved survival to adulthood, many patients will continue to have problems with residual shunts, valvular heart disease, ventricular dysfunction, heart failure and arrhythmias.  The risk of sudden death in adults with congenital heart disease is nearly 25-50 times greater than would be expected for their age.  The Adolescent and Adult Congenital Heart Disease Program at Columbus Children's Hospital and The Ohio State University Medical Center was created to meet the medical and surgical needs of this unique and complex population.  The program is comprised of experts with an understanding of the natural history of congenital heart disease as well as the care after surgical or specialized transcatheter therapy.

Fellowship Training and Cardiovascular Services include:

• Medical and surgical evaluations
• Advanced cardiac imaging
• Cardiovascular magnetic resonance
• Multidetector computed tomography
• Cardiac catheterization and interventional procedures
  • Balloon valvuloplasty and angioplasty:  all cardiac valves, arteries and veins
  • Transcatheter closure of intra and extracardiac shunts: ASDs, PFOs, VSDs, PDAs
  • Stent therapy for vascular obstructions associated with congenital heart disease: PA stenosis, coarctation of the aorta, venous obstruction
  • Unique availability of new medical devices restricted to FDA sponsored clinical trials
• Electrophysiologic procedures
  • Diagnostic EP
  • SVT/VT ablation
  • Atrial fibrillation/flutter ablation associated with congenital heart disease
  • Pacer/ICD implantation
• Cardiopulmonary exercise testing
• Heart failure/transplant evaluation
• Pulmonary hypertension services
  • Intravenous and subcutaneous prostacyclin therapy
  • Oral endothelin blockers
  • Clinical trials
• Pregnancy and heart disease
  • Medical, surgical and transcatheter therapies for cardiovascular high risk pregnancies
• Comprehensive cardiothoracic surgical repair
• Valve repair/replacement
• Ross procedure:  pulmonary autograft aortic valve replacement
• Surgical therapies of arrhythmias
• Fontan revision
• Aortic valve-sparing aortic root replacement (Marfan syndrome)

For more information regarding the training program, please contact:

Curt J. Daniels, MD

Director, Adolscent and Adult Congenital Heart Disease Program

The Heart Center at Nationwide Children’s Hospital

Director, Pulmonary Hypertension Services, OSU

Assistant Professor of Clinical Internal Medicine and Pediatrics

The Ohio State University

Office Children’s:  614-722-2530

Office OSU:  614-293-4967

Email:  Curt.Daniels@osumc.edu

Timothy M. Hoffman, MD, FACC

Director, Pediatric Cardiology Fellowship Program, Nationwide Children's Hospital

Associate Professor of Pediatrics, The Ohio State University College of Medicine

Medical Director, Heart Transplant and Heart Failure Program, Nationwide Children’s Hospital

Office:  614-722-2530

Email:  timothy.hoffman@NationwideChildrens.org